Lindahl was legal counsel to Senzime AB (publ) in connection with the company’s rights issue
Lindahl was legal counsel to Senzime AB (publ) in connection with the company’s rights issue which was resolved by the board of directors on 23 January 2023 and approved at an extraordinary general meeting on 16 February 2023.
The purpose of the rights issue is to enable the company’s continued growth journey. Through the rights issue, Senzime will receive proceeds of approximately SEK 91.9 million before deduction of transaction costs.
Senzime’s share is listed on Nasdaq Stockholm Main Market and the company develops, manufactures and markets CE- and FDA-cleared patient monitoring systems with the vision of a world without anesthesia- and respiratory-related complications.
Lindahl’s team consisted of Helena Lindbäck, Michaela Larsson, Erika Svensson and Mattias Prage.
Do you want to know more? Contact:
Helena Lindbäck
Counsel | AdvokatMichaela Larsson
Associate | AdvokatErika Svensson
Partner | AdvokatMattias Prage
Partner | AdvokatCarousel items
-
Cases and transactions
5/14/2025
Lindahl advises Heba in connection with buyback program
Lindahl advises Heba Fastighets AB in connection with the company’s repurchase of its own series B shares.
-
Knowledge
4/30/2025
New rules on review and damages for violations of EU law provisions
The government has decided on a bill proposing amendments to the procurement legislation. Among other things, it is proposed that suppliers' rights to legal remedies, in the form of review and damages, be clarified in the procurement laws concerni...
-
News articles
4/11/2025
Lindahl awarded at the Managing IP Awards
Lindahl has been named the winner in the category Sweden Trademark Prosecution (Law Firms) at the Managing IP EMEA Awards 2025.
-
Read more news and insights?
